Sarasin & Partners LLP, a registered investment adviser, initiated a new position in Colgate-Palmolive Company (NYSE:CL) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 4,347,768 shares of the Consumer Defensive company, valued at approximately $343,560,628 as of the filing date.
Colgate-Palmolive Company's stock currently trades at $78.78 with a market capitalization of $62,273,822,531.
